Question 1

What is Ironwood Pharmaceuticals's deferred tax assets and other non-current assets?

Accepted Answer

Ironwood Pharmaceuticals (IRWD) reported deferred tax assets and other non-current assets of $3.87M in Q2 2026.

Question 2

How has Ironwood Pharmaceuticals's deferred tax assets and other non-current assets changed year-over-year?

Accepted Answer

Ironwood Pharmaceuticals's deferred tax assets and other non-current assets decreased by 24.8% year-over-year, from $5.15M to $3.87M.

Question 3

What is the long-term trend for Ironwood Pharmaceuticals's deferred tax assets and other non-current assets?

Accepted Answer

Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's deferred tax assets and other non-current assets has grown at a 36.7% compound annual growth rate (CAGR), from $943K to $4.5M.

Question 4

What does deferred tax assets and other non-current assets mean?

Accepted Answer

Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.

Line item	June 30, 2026	December 31, 2025
Operating lease right-of-use assets	8,443	9,340
Intangible assets, net	1,633	2,040
Deferred tax assets	69,064	103,433
Other assets	3,874	4,502
Total assets	$285,128	$396,901
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable	$911	$2,898

Deferred Tax Assets and Other Non-Current Assets at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Ironwood Pharmaceuticals's deferred tax assets and other non-current assets.

Ironwood Pharmaceuticals IRWD Deferred Tax Assets and Other Non-Current Assets